AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Completed · Phase 2

Conditions studied: Psoriasis

In brief

The purpose of this study is to determine whether AN2728 topical ointment is a safe and effective treatment for mild-to-moderate plaque-type psoriasis.

Key facts

Study ID
NCT01300052
Run by
Pfizer
People needed
68
Starts
2011-01-26
Expected to finish
2011-06-06
Last updated by the study team
2017-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.